Licensed by the DEA, Impact Canine Solutions is dedicated to promoting a drug free environment in schools and businesses by utilizing drug sniffing dogs.
[8]. Cheng SL,et al.Int J Chron Obstruct Pulmon Dis . 2016 Sep 21;11 2341-2348. [9]. Cheng SL, et al.Drug Des Devel Ther. 2014 May 28;8:601-7. [10]. Zheng JP, et al. Chest. 2007 Dec;132(6):1756-63. [11...
摘要号:563 标题:Biofeedback-Assisted Pelvic Floor Muscle Training Combined with a Short-Duration Drug Regimen is Safe and Effective in Women with Overactive Bladder: A Randomized Controlled Trial 中文标题:生物反馈辅助盆底肌训练联...
Show Categories Show Brands Show Product ListAlbuterol Artemether Cefixime Diclofenac (Na) Dimenhydrinate Iron Hydroxide Poly Maltose Complex Lumefantrine Moxifloxacin Orphenadrine Paracetamol Zinc SulphateSearch DrugInfoSys About Us Site designed by Pharma Professional Services and developed by Hasan Computing ...
Stempeutics is committed to delivering safe, effective, and affordable stem cell based products. Currently, we are focusing on our flagship product: Stempeucel® drug. It is an on-demand, off-the-shelf product based on pooled, allogeneic Mesenchymal Stromal Cells derived from the bone marrow...
March 27, 2025 Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly SAN DIEGO , March 27, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX)...
TM A brilliant drug delivery solution World’s first. Super fast. Super effective Microbee Too tiny to be visible Mixable. Customizable TM 10X FASTER 1000X HIGHER Drug delivery capability Learn more Simple & minimalist formulation approach
FDA Prescription Drug User Fee Act (PDUFA) target action date ofSeptember 25, 2025for paltusotine NDA for the treatment and maintenance therapy of acromegaly. Enrollment of the first patient in the pivotal Phase 3 trial of paltusotine in carcinoid syndrome is anticipated in the second...
Crinetics Announces European Medicines Agency Validation of Marketing Authorization Application and Orphan Drug Designation for Paltusotine in Acromegaly Press Release A company as rare as the diseaseswe focus on. Few companies focus exclusively on endocrine diseases. We do. Many patients have longed fo...
addictions and alcohol and other drug (AOD) sector - covering other disciplines and methodologiesinsights, international assortment of leaders in AOD fieldgreater cooperation, between disciplines and methodological flexibility and sophisticationprocess of careful planning and brainstorming - best accomplished ...